MRI-based radiomics is being studied for predicting 2-year recurrence in anal squamous cell carcinoma, marking a step forward in personalized treatment planning. By extracting quantitative features from medical images, radiomics goes beyond traditional visual interpretation to predict clinical outcomes.
The integration of artificial intelligence (AI) enhances radiomic models, using machine learning to evaluate imaging data and improve anal cancer assessment.
Functional imaging advances, such as diffusion-weighted imaging (DWI), multiparametric MRI (mpMRI), and perfusion MRI, provide more accurate evaluation of tumor response and staging by adding functional insights to conventional anatomical imaging. These methods offer measurable biomarkers for treatment monitoring.
Despite progress, challenges remain in achieving standardized, high-quality scans across imaging centers. Continued technical improvements and standardization are essential.
Future directions include radiogenomics, which combines imaging data with genomic profiles for precision medicine, and advanced machine learning models that integrate radiomic and clinical features to improve early prediction of treatment response.
Overall, these innovations signal a shift toward AI-enhanced, quantitative, multiparametric approaches that promise more accurate prognostication and treatment personalization for anal cancer patients.